Weight loss in Tamil Ayurveda vs DeepThink PTB使用状況と統計

DeepThink Health Precision Tumor Board ™ Advancing medicine with precision intelligence ™ DeepThink Health has developed an innovative precision intelligence platform which captures and structures large clinical and genomic datasets, and then applies our advanced analytics and machine learning to enable precision medicine. Just as in the desktop Precision Tumor Board application, in our mobile app we’ve integrated and processed a cancer patient’s molecular/genomic tumor report enabling Molecular Tumor Board and Standard Tumor Board to quickly interpret the complex data for oncologists urgently needing to prescribe the right therapies for their cancer patients. Tumor Board members can: • Quickly see FDA approved therapies with predictive responses for the patient’s specific tumor type and genetic characteristics • Easily select among targeted therapies based on biomarkers or suggest therapies to enhance the molecular report interpretation • See clinical trials already screened for the patient case in context • Collaborate with other Molecular Tumor Board members to quickly and timely provide a succinct report to the treating oncologist • Schedule and hold virtual tumor board meeting • No private health information is stored or relayed in the application, DeepThink Health products are HIPAA compliant. About DeepThink Health DeepThink Health has developed an innovative precision intelligence platform which captures and structures large clinical and genomic datasets, and then applies our advanced analytics and machine learning to enable precision medicine. Our team has extensive experience and success in leading Healthcare IT companies serving providers, payers and pharmacies. Our Precision Analytics and Precision Intelligence solutions have been successfully implemented at large Healthcare IDNs where the combined genomic, clinical and outcome data were analyzed using DeepThink Artificial Intelligence tools to advance precision medicine and enable novel discoveries.